(Q39755457)

14 September 2017

title

Epstein-Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia (English)

1 reference

14 September 2017

0 references

0 references

1 reference

1 reference

4

Susan O'Brien

1 reference

14 September 2017

2

Michael J Keating

1 reference

Apostolia Maria Tsimberidou

14 September 2017

3

object named as

Apostolia M Tsimberidou

1 reference

14 September 2017

Jeffrey J Tarrand

1

1 reference

14 September 2017

Rocco P LaSala

5

1 reference

14 September 2017

Xiang-Yang Han

6

1 reference

14 September 2017

Carlos E Bueso-Ramos

7

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

116

1 reference

14 September 2017

issue

4

1 reference

14 September 2017

page(s)

880-887

1 reference

In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Epstein-Barr virus in patients with chronic lymphocytic leukemia: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Richter's transformation in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Epstein-Barr virus infection in Richter's transformation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Rapid and simple method for purification of nucleic acids

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Increased precision of microbial RNA quantification using NASBA with an internal control.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTectt HPV-Proofer assay

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Characteristics and applications of nucleic acid sequence-based amplification (NASBA).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, early D-type cyclins, Bax, and caspase-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Aurora-A kinase nuclear expression in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Epstein barr virus (EBV)‐carrying cells of a chronic lymphocytic leukemia (CLL) subpopulation express EBNA1 and LMPS but not EBNA2 in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24839

7 January 2021

Identifiers

DOI

10.1002/CNCR.24839

1 reference

14 September 2017

1 reference